Lv1
36 积分 2023-09-13 加入
Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer
7小时前
待确认
Climbing cancer’s MYC mountain
1个月前
已完结
Discovery of a Novel Macrocyclic Noncovalent CDK7 Inhibitor for Cancer Therapy
5个月前
已完结
Arginine Methyltransferase 5 (PRMT5) Inhibitors with 3-(1H-benzo[d]imidazol- 2-yl)anilines Core Identified by Virtual Screening and Biological Evaluation
6个月前
已完结
METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey
7个月前
已完结
Medicinal chemistry strategies targeting PRMT5 for cancer therapy
7个月前
已完结
Structure-based discovery of a new series of nucleoside-derived ring-opening PRMT5 inhibitors
7个月前
已完结
Molecular design of dual inhibitors of PI3K and potential molecular target of cancer for its treatment: A review
7个月前
已完结
XS-2, a novel potent dual PI3K/mTOR inhibitor, exhibits high in vitro and in vivo anti-breast cancer activity and low toxicity with the potential to inhibit the invasion and migration of triple-negative breast cancer
7个月前
已完结
Design, synthesis and pharmacological evaluation of 2-arylurea-1,3,5-triazine derivative (XIN-9): A novel potent dual PI3K/mTOR inhibitor for cancer therapy
7个月前
已完结
皖公网安备34019202002308
